PJ
Pragneshkumar Jayantilal Pathak
About Pragneshkumar Jayantilal Pathak
Data last updated:
Pragneshkumar Jayantilal Pathak has 6 years in corporate governance. Holds Director role. Currently with 1 company, including Captalo Pharma Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Captalo Pharma Private Limited at ₹3.61 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Captalo Pharma Private Limited U33119GJ2020PTC113595 | Director | 20 May 2020 | 2020 | ₹3.61 Cr (FY 2024) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pragneshkumar Jayantilal Pathak
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pragneshkumar Jayantilal Pathak
Pragneshkumar Jayantilal Pathak has 6 years in corporate governance. Holds Director role. Currently with 1 company, including Captalo Pharma Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Captalo Pharma Private Limited at ₹3.61 Cr (FY 2024).
Pragneshkumar Jayantilal Pathak is associated with 1 company as Director, including Captalo Pharma Private Limited (₹3.61 Cr).
Pragneshkumar Jayantilal Pathak has expertise in General Business.
Pragneshkumar Jayantilal Pathak has 6 years in corporate governance.
By reported revenue, the largest current company of Pragneshkumar Jayantilal Pathak is Captalo Pharma Private Limited, with revenue of ₹3.61 Cr (FY 2024).
Pragneshkumar Jayantilal Pathak currently holds positions at 1 company: Captalo Pharma Private Limited (₹3.61 Cr).